From: Serum tau protein elevation in migraine: a cross-sectional case–control study
[A] Biomarker | Healthy control (HC) n = 42 | Episodic migraine without aura (EMO) n = 49 | Episodic migraine with aura (EMA) n = 43 | p-values a | Multiple variable adjusted p-valueb |
---|---|---|---|---|---|
t-tau | 0.200 (0.114 to 0.288) | 0.332 (0.234 to 0.449)c | 0.291 (0.184 to 0.486)c | 0.004* | 0.002* |
NfL | 7.5 (6.0 to 9.0) | 7.2 (5.9 to 8.0) | 6.6 (5.4 to 10.0) | 0.637 | 0.769 |
GFAP | 69.4 (54.7 to 90.0) | 66.8 (53.0 to 95.0) | 70.3 (48.5 to 97.0) | 0.965 | 0.696 |
UCH-L1 | 0.120 (0.120 to 0.357) | 0.120 (0.120 to 5.17) | 0.120 (0.120 to 4.645) | 0.210 | 0.150 |
[B] Biomarker | Healthy control (HC) n = 42 | Chronic migraine without prophylaxis (CM-) n = 48 | Chronic migraine with prophylaxis (CM +) n = 45 | p-valuesa | Multiple variable adjusted p-valueb |
t-tau | 0.200 (0.114 to 0.288) | 0.322 (0.181 to 0.463)c | 0.293 (0.126 to 0.375) | 0.012* | 0.015* |
NfL | 7.5 (6.0 to 9.0) | 7.8 (5.4 to 12.0) | 7.3 (5.1 to 11.0) | 0.693 | 0.201 |
GFAP | 69.4 (54.7 to 90.0) | 78.2 (56.7 to 106.0) | 65.8 (49.0 to 100.0) | 0.490 | 0.313 |
UCH-L1 | 0.120 (0.120 to 0.357) | 0.241 (0.120 to 2.446) | 0.120 (0.120 to 1.025) | 0.083 | 0.104 |